Entries by Vered Albelda

Congress Saves NIH Budget!

Congress: NIH Budget Will Not Be Cut Congress Inks Spending Deal That Jettisons Trump Priorities – Bloomberg News, May 1, 2017 U.S. House and Senate negotiators reached a tentative bipartisan deal on a $1.1 trillion spending bill that largely tracks with Democratic priorities and rejects most of President Donald Trump’s wish list. Overall, the compromise […]

Investment for Advanced Therapies – May 3, 2017

FreeMind is proud to support the upcoming Investment for Advanced Therapies event! When: May 3, 2017 Where: London, UK Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your […]

MedFIT – Fostering Innovation in medTech

FreeMind is pleased to support the upcoming MedFIT event!   Where: Grenoble, France When: June 28-29, 2017   A 360° approach to build innovation partnerships, source licensing deals and accelerate market access in medtech.   Organised by Eurasanté and the NHL Cluster, with the support of Medicalps and Alsace BioValley, the 1st edition of MedFIT will gather […]

BioTrinity 2017

The FreeMind Group is proud to support the upcoming BioTrinity conference! Where: London, UK When: May 8-10, 2017 BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK. Now in its 11th year, the aim of BioTrinity is simple – create an ideal networking and partnering platform for life science companies […]

Available Online: Introduction to SBIR and STTR Funding Opportunities Webinar

Opening FreeMind’s 2017 webinar series is an introduction to the SBIR and STTR mechanisms which account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics. SBIR/STTRs differ from traditional NIH mechanisms in that they […]